• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小儿骨肉瘤和尤文肉瘤恶性骨肿瘤化疗治疗反应的定量扩散加权磁共振成像评估

Quantitative diffusion-weighted magnetic resonance imaging assessment of chemotherapy treatment response of pediatric osteosarcoma and Ewing sarcoma malignant bone tumors.

作者信息

Degnan Andrew J, Chung Chul Y, Shah Amisha J

机构信息

Department of Radiology, University of Pittsburgh Medical Center, Pittsburgh, PA, United States; Department of Pediatric Radiology, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA, United States; Department of Radiology, The Children's Hospital of Philadelphia, Philadelphia, PA, United States.

Department of Radiology, University of Pittsburgh Medical Center, Pittsburgh, PA, United States; Department of Pediatric Radiology, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA, United States.

出版信息

Clin Imaging. 2018 Jan-Feb;47:9-13. doi: 10.1016/j.clinimag.2017.08.003. Epub 2017 Aug 5.

DOI:10.1016/j.clinimag.2017.08.003
PMID:28806574
Abstract

OBJECTIVE

Assessment of tumor response to chemotherapy is essential in managing malignant pediatric bone tumors prior to resection.

SUBJECTS AND METHODS

Pre-chemotherapy and post-chemotherapy osteosarcoma and Ewing sarcoma cases (n=18) were analyzed with apparent diffusion coefficient (ADC) values measured by two readers.

RESULTS

Treated tumors demonstrated significantly greater ADC values compared to untreated tumors (p<0.001). Intraclass correlation coefficients ranged between 0.858 and 0.935. No significant tumor volume differences were observed. Regression analysis demonstrated average ADC as the best predictor of treatment.

CONCLUSIONS

Our study suggests that ADC values may be useful for evaluating chemotherapeutic response of malignant pediatric bone tumors.

摘要

目的

在切除恶性小儿骨肿瘤之前,评估肿瘤对化疗的反应对于治疗管理至关重要。

对象与方法

对18例化疗前和化疗后的骨肉瘤及尤文肉瘤病例,由两位阅片者测量表观扩散系数(ADC)值进行分析。

结果

与未治疗的肿瘤相比,接受治疗的肿瘤显示出明显更高的ADC值(p<0.001)。组内相关系数在0.858至0.935之间。未观察到明显的肿瘤体积差异。回归分析表明平均ADC是治疗效果的最佳预测指标。

结论

我们的研究表明,ADC值可能有助于评估恶性小儿骨肿瘤的化疗反应。

相似文献

1
Quantitative diffusion-weighted magnetic resonance imaging assessment of chemotherapy treatment response of pediatric osteosarcoma and Ewing sarcoma malignant bone tumors.小儿骨肉瘤和尤文肉瘤恶性骨肿瘤化疗治疗反应的定量扩散加权磁共振成像评估
Clin Imaging. 2018 Jan-Feb;47:9-13. doi: 10.1016/j.clinimag.2017.08.003. Epub 2017 Aug 5.
2
Multiparametric MRI with diffusion-weighted imaging in predicting response to chemotherapy in cases of osteosarcoma and Ewing's sarcoma.磁共振多参数成像弥散加权成像预测骨肉瘤和尤文肉瘤化疗反应的价值。
Br J Radiol. 2020 Nov 1;93(1115):20200257. doi: 10.1259/bjr.20200257. Epub 2020 Oct 15.
3
The value of diffusion weighted imaging and apparent diffusion coefficient in primary Osteogenic and Ewing sarcomas for the monitoring of response to treatment: Initial experience.弥散加权成像及表观弥散系数在原发性成骨肉瘤和尤因肉瘤治疗反应监测中的价值:初步经验。
Eur J Radiol. 2020 Mar;124:108855. doi: 10.1016/j.ejrad.2020.108855. Epub 2020 Jan 28.
4
Diffusion-weighted imaging for the differentiation of Ewing sarcoma from osteosarcoma.弥散加权成像在鉴别尤因肉瘤与骨肉瘤中的应用。
Skeletal Radiol. 2021 Oct;50(10):2023-2030. doi: 10.1007/s00256-021-03741-8. Epub 2021 Apr 2.
5
Correlation between apparent diffusion coefficient and histopathology subtypes of osteosarcoma after neoadjuvant chemotherapy.新辅助化疗后骨肉瘤的表观扩散系数与组织病理学亚型之间的相关性
Acta Radiol. 2017 Aug;58(8):971-976. doi: 10.1177/0284185116678276. Epub 2016 Nov 16.
6
Monitoring therapeutic responses of primary bone tumors by diffusion-weighted image: Initial results.通过扩散加权成像监测原发性骨肿瘤的治疗反应:初步结果。
Eur Radiol. 2006 Dec;16(12):2637-43. doi: 10.1007/s00330-006-0342-y. Epub 2006 Aug 15.
7
Osteosarcoma: preliminary results of in vivo assessment of tumor necrosis after chemotherapy with diffusion- and perfusion-weighted magnetic resonance imaging.骨肉瘤:化疗后通过扩散加权磁共振成像和灌注加权磁共振成像进行肿瘤坏死体内评估的初步结果
Invest Radiol. 2006 Aug;41(8):618-23. doi: 10.1097/01.rli.0000225398.17315.68.
8
Pediatric Malignant Bone Tumors: A Review and Update on Current Challenges, and Emerging Drug Targets.小儿恶性骨肿瘤:当前挑战及新兴药物靶点的综述与更新
Curr Probl Pediatr Adolesc Health Care. 2016 Jul;46(7):213-228. doi: 10.1016/j.cppeds.2016.04.002. Epub 2016 Jun 2.
9
The sensitivity, specificity, and diagnostic accuracy of whole-bone MRI for identifying skip metastases in appendicular osteosarcoma and Ewing sarcoma.全骨 MRI 识别四肢骨肉瘤和尤文肉瘤跳跃转移的敏感性、特异性和诊断准确性。
Skeletal Radiol. 2020 Jun;49(6):913-919. doi: 10.1007/s00256-019-03364-0. Epub 2020 Jan 4.
10
The value of diffusion-weighted imaging for monitoring the chemotherapeutic response of osteosarcoma: a comparison between average apparent diffusion coefficient and minimum apparent diffusion coefficient.弥散加权成像在监测骨肉瘤化疗反应中的价值:平均表观弥散系数与最小表观弥散系数的比较。
Skeletal Radiol. 2010 Feb;39(2):141-6. doi: 10.1007/s00256-009-0830-7. Epub 2009 Nov 19.

引用本文的文献

1
Preliminary exploration of amide proton transfer weighted imaging in differentiation between benign and malignant bone tumors.酰胺质子转移加权成像在鉴别良恶性骨肿瘤中的初步探索
Front Oncol. 2024 Jun 6;14:1402628. doi: 10.3389/fonc.2024.1402628. eCollection 2024.
2
Evaluation of the neoadjuvant chemotherapy response in osteosarcoma using the MRI DWI-based machine learning radiomics nomogram.使用基于MRI扩散加权成像的机器学习影像组学列线图评估骨肉瘤新辅助化疗反应
Front Oncol. 2024 Mar 21;14:1345576. doi: 10.3389/fonc.2024.1345576. eCollection 2024.
3
Ewing sarcoma of the temporal bone with aneurysmal bone cyst-like changes: A rare case report with an unusual radiological presentation.
颞骨尤文肉瘤伴动脉瘤样骨囊肿样改变:一种罕见病例报告并伴有不典型影像学表现。
Neuroradiol J. 2024 Oct;37(5):640-644. doi: 10.1177/19714009231212358. Epub 2023 Nov 3.
4
Monitoring early responses to neoadjuvant chemotherapy and the factors affecting neoadjuvant chemotherapy responses in primary osteosarcoma.监测原发性骨肉瘤对新辅助化疗的早期反应及影响新辅助化疗反应的因素。
Quant Imaging Med Surg. 2023 Jun 1;13(6):3716-3725. doi: 10.21037/qims-22-1095. Epub 2023 May 9.
5
The Development of Naringin for Use against Bone and Cartilage Disorders.柚皮苷在防治骨与软骨疾病中的应用进展。
Molecules. 2023 Apr 25;28(9):3716. doi: 10.3390/molecules28093716.
6
Pitfalls of Diffusion-Weighted Imaging: Clinical Utility of T2 Shine-through and T2 Black-out for Musculoskeletal Diseases.扩散加权成像的陷阱:T2 透过效应和 T2 信号缺失在肌肉骨骼疾病中的临床应用
Diagnostics (Basel). 2023 May 7;13(9):1647. doi: 10.3390/diagnostics13091647.
7
Methodological considerations on segmenting rhabdomyosarcoma with diffusion-weighted imaging-What can we do better?关于利用扩散加权成像对横纹肌肉瘤进行分割的方法学考量——我们能做得更好吗?
Insights Imaging. 2023 Jan 31;14(1):19. doi: 10.1186/s13244-022-01351-z.
8
3D vs. 2D MRI radiomics in skeletal Ewing sarcoma: Feature reproducibility and preliminary machine learning analysis on neoadjuvant chemotherapy response prediction.骨骼尤文肉瘤中3D与2D MRI影像组学:特征可重复性及新辅助化疗反应预测的初步机器学习分析
Front Oncol. 2022 Dec 2;12:1016123. doi: 10.3389/fonc.2022.1016123. eCollection 2022.
9
Imaging of pediatric bone tumors: A COG Diagnostic Imaging Committee/SPR Oncology Committee White Paper.儿童骨肿瘤的影像学:COG 诊断成像委员会/SPR 肿瘤学委员会白皮书。
Pediatr Blood Cancer. 2023 Jun;70 Suppl 4(Suppl 4):e30000. doi: 10.1002/pbc.30000. Epub 2022 Oct 17.
10
Multiparametric MRI evaluation of bone sarcomas in children.儿童骨肉瘤的多参数磁共振成像评估
Insights Imaging. 2022 Mar 1;13(1):33. doi: 10.1186/s13244-022-01177-9.